Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04943900
Title A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

pancreatic ductal adenocarcinoma

lung non-small cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma

hepatocellular carcinoma

Therapies

BMS-986416 + Nivolumab

BMS-986416

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Local Institution Not yet recruiting Atlanta Georgia 30322 United States Details
Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics Recruiting Baltimore Maryland 21287 United States Details
John Theurer Cancer Center Recruiting Hackensack New Jersey 07601 United States Details
University Hospitals Cleveland Medical Center Recruiting Cleveland Ohio 44106-5055 United States Details
UPMC Hillman Cancer Center Recruiting Pittsburgh Pennsylvania 15232 United States Details
University of Texas MD Anderson Cancer Center-Investigational Cancer Therapeutics Recruiting Houston Texas 77030 United States Details
Local Institution Not yet recruiting Toronto Ontario M5G 1Z5 Canada Details
Local Institution - 0001 Recruiting Montréal Quebec H2X 3H8 Canada Details
Local Institution Not yet recruiting Edmonton T6G 1Z2 Canada Details
Local Institution - 0010 Recruiting Chuo-ku Tokyo 104-0045 Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field